Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.480
-0.090 (-2.52%)
Apr 29, 2026, 11:51 AM EDT - Market open
Artelo Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.6 | 2.34 | 2.82 | 6.89 | 12.16 | Upgrade
|
| Short-Term Investments | - | - | - | 1.5 | - | Upgrade
|
| Trading Asset Securities | - | - | 7.61 | 9.15 | 11.95 | Upgrade
|
| Cash & Short-Term Investments | 0.6 | 2.34 | 10.43 | 17.53 | 24.11 | Upgrade
|
| Cash Growth | -74.34% | -77.58% | -40.53% | -27.29% | 139.57% | Upgrade
|
| Prepaid Expenses | 0.1 | 0.22 | 0.55 | 0.79 | 0.5 | Upgrade
|
| Total Current Assets | 0.7 | 2.56 | 10.98 | 18.32 | 24.61 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0.1 | 0.02 | 0.06 | 0.08 | Upgrade
|
| Long-Term Investments | - | - | - | - | 1.52 | Upgrade
|
| Other Intangible Assets | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 2.8 | 4.7 | 13.04 | 20.42 | 28.25 | Upgrade
|
| Accounts Payable | 3.04 | 1.68 | 1.24 | 0.91 | 0.98 | Upgrade
|
| Accrued Expenses | 0.36 | 0.06 | 0.03 | 0.05 | 0.02 | Upgrade
|
| Short-Term Debt | 0.61 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | Upgrade
|
| Other Current Liabilities | 0 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 4.04 | 1.77 | 1.29 | 1 | 1.03 | Upgrade
|
| Long-Term Leases | 0.03 | 0.07 | - | 0.02 | 0.06 | Upgrade
|
| Total Liabilities | 4.07 | 1.84 | 1.29 | 1.02 | 1.08 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 62.01 | 53.19 | 52.26 | 50.68 | 48.12 | Upgrade
|
| Retained Earnings | -63.02 | -50.14 | -40.31 | -31.02 | -20.94 | Upgrade
|
| Comprehensive Income & Other | -0.27 | -0.2 | -0.2 | -0.25 | -0.02 | Upgrade
|
| Shareholders' Equity | -1.27 | 2.86 | 11.75 | 19.4 | 27.17 | Upgrade
|
| Total Liabilities & Equity | 2.8 | 4.7 | 13.04 | 20.42 | 28.25 | Upgrade
|
| Total Debt | 0.68 | 0.1 | 0.02 | 0.06 | 0.09 | Upgrade
|
| Net Cash (Debt) | -0.08 | 2.23 | 10.4 | 17.47 | 24.03 | Upgrade
|
| Net Cash Growth | - | -78.53% | -40.45% | -27.28% | 140.97% | Upgrade
|
| Net Cash Per Share | -0.23 | 12.48 | 63.26 | 111.00 | 193.92 | Upgrade
|
| Filing Date Shares Outstanding | 0.71 | 0.18 | 0.18 | 0.16 | 0.16 | Upgrade
|
| Total Common Shares Outstanding | 0.67 | 0.18 | 0.18 | 0.16 | 0.16 | Upgrade
|
| Working Capital | -3.35 | 0.79 | 9.69 | 17.32 | 23.58 | Upgrade
|
| Book Value Per Share | -1.89 | 15.67 | 66.33 | 122.30 | 173.40 | Upgrade
|
| Tangible Book Value | -3.31 | 0.82 | 9.71 | 17.36 | 25.13 | Upgrade
|
| Tangible Book Value Per Share | -4.92 | 4.49 | 54.82 | 109.45 | 160.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.